News in brief: Filippis exits Neurotech; Elixinol completes US sale by Adam Sheldon September 8, 2026September 8, 2026 Neurotech International chief executive and managing director Dr Anthony Filippis has resigned after 19 months in […]
Autism data hits ‘registration benchmark’ as Neurotech prepares for Phase III clinical trial by Adam Sheldon March 25, 2026March 26, 2026
Cannabis executive salaries: who earned what in FY25 by Adam Sheldon October 22, 2025October 22, 2025